Accentia Biopharmaceuticals News and Articles

Return to Library

Recent Accentia Biopharmaceuticals News and Articles

• Accentia Biopharmaceuticals Inc. Files SEC Form 8-K, Current Report (Nov. 23, 2012)
• Biovest to Present BiovaxID(TM) Cancer Vaccine Update at Lymphoma Coalition Patient Advocacy Event prior to ASH Meeting
• Accentia Biopharmaceuticals Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-K Item 405] (Dec. 26, 2012)

Accentia Biopharmaceuticals Inc. Files SEC Form 8-K, Current Report (Oct. 15, 2012)

The SIC code for this company is 2834, Pharmaceutical Preparations.

There was one document filed with this form. The SEC file number is 0001193125-12-423516.

The contact information for this company is 324 SOUTH HYDE PARK AVE, SUITE 350, TAMPA FL 33606, 813.864.2554.

Our editors provided additional information about Form 8-K: This is the "current report" that is used to report the occurrence of any material events or corporate changes which are of importance to investors or security holders and previously have not been reported by the registrant. It provides more current information on certain specified events than would Forms 10-Q or 10-K.

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1310094/0001193125-12-423516-index.html.

Keywords for this news article include: Pharmaceutical Preparations, Drugs, Therapy, SEC Filing, Accentia Biopharmaceuticals Inc..

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC